Glaukos Reports 2017 Net Sales of $159.3 Million

March 9, 2018: By Joan McKenna

Glaukos reported Feb. 28 that 2017 net sales of its iStent implant totaled $159.3 million, a 39 percent increase over 2016 sales of $114.4 million.

Glaukos’ Q4-2017 net sales totaled $41.7 million, an increase of 26 percent year over year.

The San Clemente, California, company attributed the growth to unit volume increases worldwide, higher average selling prices, and expansion of the company’s direct sales operations to new international markets.

Glaukos launched the iStent, the first minimally invasive glaucoma surgery (MIGS) device, in 2012.

The device now faces growing competition, with other MIGS stents commercialized in late 2016 and 2017.

Glaukos provided net sales guidance for 2018 of $160 million to $165 million, the same range the firm initially provided for 2017.

In May 2017, Glaukos’ full-year guidance for 2017 was raised to $162 million to $167 million. In September 2017, the company lowered it to $155 million to $160 million.

Glaukos’ net loss in 2017 was $0.1 million compared with net income of $4.5 million in 2016.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Bausch + Lomb Inks Deal with Express Scripts Expanding Vyzulta Coverage

Melgen Seeks Bond, Appeals Conviction on Charges of Medicare Fraud

Avedro, FDA Agree on Design, Size of First Pivotal Phase III Trial for Epi-on Cross-linking

Iridex Reports 2017 Revenues of $41.6 Million

Bar-Ilan University Announces Nano-Drop Candidate to Correct Refractive Error

Essex Bio-Technology Agrees to Invest $5 Million in MeiraGTx, Developer of Gene Therapies

Clearside Biomedical Announces $85 Million Public Offering

ViewPoint Raises $35 Million for Topical Treatment Candidate for Cataracts, Presbyopia

Okogen Raises $10 Million in Series A Round for Viral Conjunctivitis Candidate

SightLife Surgical Acquires KAMRA Corneal Inlay from AcuFocus

Major Leaguer Tommy Pham Plays Through Keratoconus

Glaukos Reports 2017 Net Sales of $159.3 Million

Imprimis Posts 2017 Revenues of $26.77 Million, a 34 Percent Increase

STAAR’s 2017 Net Sales Total $90.6 Million

US FDA Warns Consumers Not to Use Products from Cantrell Drug Company

IDx’ AI-Based Diagnostics System Meets Endpoints in Pivotal Trial for DR

Aerie Plans to Launch Rhopressa in Q2-2018, Expects 2018 Revenues of $20 Million to $30 Million

Valeant Reports 2017 Revenues of $8.72 Billion, a Decline of 10 Percent

Carl Zeiss Meditec Reports $359.7 Million in Revenues for First Quarter of FY2018, a 5.3 Percent Increase

Ophthotech Partners with UMass to Develop ‘Minigene’ Therapy for Retinal Disease

Coming soon

2018 IOL Report: A Global Market Analysis for 2017 to 2023